ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,725
0,16%
Bitcoin
66 319,58
0,07%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cypress Bioscience, Inc. (MM) (CYPB)

  7. Cypress Bioscience, Inc. (MM) (CYPB) Actualités

CYPB

Cypress Bioscience (CYPB)

Cypress Bioscience, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CYPB
DateHeureSourceTitreSymboleSociété
14/01/201112h01Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
14/01/201112h01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
14/01/201112h01Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
06/01/201114h00PR Newswire (US)Ramius and Royalty Pharma Announce Successful Conclusion of Cypress Bioscience Tender OfferNASDAQ:CYPBCypress Bioscience, Inc. (MM)
04/01/201123h06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
04/01/201114h30MarketwiredFTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino ActNASDAQ:CYPBCypress Bioscience, Inc. (MM)
04/01/201112h03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
29/12/201019h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
23/12/201022h21Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
22/12/201022h08Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
22/12/201012h06Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
21/12/201014h45PR Newswire (US)Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger AgreementNASDAQ:CYPBCypress Bioscience, Inc. (MM)
20/12/201023h20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
20/12/201018h26Business WireCypress Bioscience, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Ramius V&O Acquisition, LLCNASDAQ:CYPBCypress Bioscience, Inc. (MM)
17/12/201019h59Business WireThe Law Office of Abe Shainberg Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Cypres...NASDAQ:CYPBCypress Bioscience, Inc. (MM)
17/12/201001h30Business WireLaw Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Cypress Bioscience, Inc., in Connection w...NASDAQ:CYPBCypress Bioscience, Inc. (MM)
16/12/201017h26Business WireThe Law Firm of Levi & Korsinsky, LLP Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ...NASDAQ:CYPBCypress Bioscience, Inc. (MM)
15/12/201020h49Business WireThe Law Firm of Weiss & Lurie Investigates the Acquisition of Cypress Bioscience, Inc. by Ramius V&O Acquisition LLC & Royalt...NASDAQ:CYPBCypress Bioscience, Inc. (MM)
15/12/201014h00Business WireCypress Bioscience Agrees To Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share in CashNASDAQ:CYPBCypress Bioscience, Inc. (MM)
14/12/201016h51PR Newswire (US)Cypress Board Rejects Ramius' $6.00 All-Cash OfferNASDAQ:CYPBCypress Bioscience, Inc. (MM)
10/12/201017h47Business WireCypress Bioscience Board of Directors Confirms Receipt of Revised Ramius LLC Offer in Connection with Strategic Review ProcessNASDAQ:CYPBCypress Bioscience, Inc. (MM)
10/12/201015h29PR Newswire (US)Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per ShareNASDAQ:CYPBCypress Bioscience, Inc. (MM)
09/11/201014h01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CYPBCypress Bioscience, Inc. (MM)
09/11/201012h30MarketwiredCypress Bioscience Announces Third Quarter 2010 Financial ResultsNASDAQ:CYPBCypress Bioscience, Inc. (MM)
03/11/201011h30MarketwiredCypress Bioscience, Inc. to Present at Oppenheimer 21st Annual Healthcare ConferenceNASDAQ:CYPBCypress Bioscience, Inc. (MM)
02/11/201022h45PR Newswire (US)Ramius Extends Tender Offer to Acquire CypressNASDAQ:CYPBCypress Bioscience, Inc. (MM)
11/10/201019h23Dow Jones NewsUPDATE: FDA Wants More Data For Jazz Pharma Fibromyalgia DrugNASDAQ:CYPBCypress Bioscience, Inc. (MM)
08/10/201023h05MarketwiredCypress Bioscience Announces Agreement to Sell Diagnostic Business to Exagen DiagnosticsNASDAQ:CYPBCypress Bioscience, Inc. (MM)
30/09/201019h37PR Newswire (US)Ramius Sends Letter to Independent Members of the Cypress BoardNASDAQ:CYPBCypress Bioscience, Inc. (MM)
28/09/201014h21MarketwiredCypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender OfferNASDAQ:CYPBCypress Bioscience, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:CYPB

Dernières Valeurs Consultées

BIT
UI342C
Unicredit Bank
BIT
I09198
Intesa Sanpaolo
COIN
NBTKNGBP
Ninsa B Token
LBNK
SLCUSDT
Solice
COIN
CBTOETH
CommerceBlock
ASX
MGRCD
Mirvac
BOV
MLAS3
Multilaser Industrial ON
NASDAQ
TILE
Interface
LSE
0V56
Mag Silver
TG
PTX
Palantir Technologies
BTHB
EVERKRW
Everscale
NASDAQ
FZVDSX
Inflation Hedge Portfoli...
LSE
42XH
Investec Bnk 23
LSE
79SO
Investec Bnk 26
NYSE
CPTK.WS
Crown PropTech Acquisiti...
USOTC
RDEIY
Redeia Corporacion (PK)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés